Overview
A mercaptodicarboxylic acid used as an antidote to heavy metal poisoning because it forms strong chelates with them.
Indication
For the treatment of lead poisoning in pediatric patients with blood lead levels above 45 µg/dL. May also be used to treat mercury or arsenic poisoning.
Associated Conditions
- Arsenic Poisoning
- Lead Poisoning
- Mercury Poisoning
- Blood lead levels above 45 mcg/dL Lead poisoning
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/02/06 | Phase 2 | Recruiting | |||
2019/05/21 | Early Phase 1 | Recruiting | Second Affiliated Hospital, School of Medicine, Zhejiang University | ||
2018/08/15 | Phase 1 | Recruiting | |||
2013/12/23 | Phase 1 | Completed | U.S. Army Medical Research and Development Command | ||
2009/06/18 | Phase 1 | Completed | |||
2008/12/18 | Phase 1 | Completed | Southwest College of Naturopathic Medicine | ||
2006/09/14 | Phase 2 | Withdrawn | |||
2006/06/21 | Phase 3 | Completed | National Institute of Environmental Health Sciences (NIEHS) | ||
2000/02/25 | Not Applicable | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | 55292-201 | ORAL | 100 mg in 1 1 | 1/11/2023 | |
| Theragnostics Inc | 71083-0020 | INTRAVENOUS | 1 mg in 1 1 | 1/31/2024 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| RADPHARM DMSA powder for injection | 14326 | Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific | Medicine | A | 9/5/1991 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| DMSA TECHNESCAN 1 mg EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA | Curium Pharma Spain S.A. | 70131 | EQUIPO DE REACTIVOS PARA PREPARACIÓN RADIOFARMACÉUTICA | Uso Hospitalario | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.